Unknown

Dataset Information

Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysis.


ABSTRACT: Adoptive cell therapy (ACT) has shown promise in hematologic and solid tumors. While data supports immunogenicity of gynecologic cancers, the benefit of ACT is not yet clear. To address this question, we performed a comprehensive systematic review and meta-analysis. Eligible studies included those reporting oncologic response or toxicity data in at least one patient with any gynecologic cancer treated with ACT. Chi-square test and multivariable logistic regression were performed to identify predictors of response. We retrieved 281 articles, and 28 studies met our inclusion criteria. These comprised of 401 patients including 238 patients with gynecologic cancers (61.8% ovarian, 34.0% cervical, 2.9% endometrial, and 1.2% other). In patients with gynecologic cancers, response rates to ACT wer

SUBMITTER: Son J 

PROVIDER: S-EPMC9133136 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature